Cite
Friedman JE, Dobrinskikh E, Alfonso-Garcia A, et al. Pyrroloquinoline quinone prevents developmental programming of microbial dysbiosis and macrophage polarization to attenuate liver fibrosis in offspring of obese mice. Hepatol Commun. 2018;2(3):313-328doi: 10.1002/hep4.1139.
Friedman, J. E., Dobrinskikh, E., Alfonso-Garcia, A., Fast, A., Janssen, R. C., Soderborg, T. K., Anderson, A. L., Reisz, J. A., D'Alessandro, A., Frank, D. N., Robertson, C. E., de la Houssaye, B. A., Johnson, L. K., Orlicky, D. J., Wang, X. X., Levi, M., Potma, E. O., El Kasmi, K. C., & Jonscher, K. R. (2018). Pyrroloquinoline quinone prevents developmental programming of microbial dysbiosis and macrophage polarization to attenuate liver fibrosis in offspring of obese mice. Hepatology communications, 2(3), 313-328. https://doi.org/10.1002/hep4.1139
Friedman, Jacob E, et al. "Pyrroloquinoline quinone prevents developmental programming of microbial dysbiosis and macrophage polarization to attenuate liver fibrosis in offspring of obese mice." Hepatology communications vol. 2,3 (2018): 313-328. doi: https://doi.org/10.1002/hep4.1139
Friedman JE, Dobrinskikh E, Alfonso-Garcia A, Fast A, Janssen RC, Soderborg TK, Anderson AL, Reisz JA, D'Alessandro A, Frank DN, Robertson CE, de la Houssaye BA, Johnson LK, Orlicky DJ, Wang XX, Levi M, Potma EO, El Kasmi KC, Jonscher KR. Pyrroloquinoline quinone prevents developmental programming of microbial dysbiosis and macrophage polarization to attenuate liver fibrosis in offspring of obese mice. Hepatol Commun. 2018 Jan 22;2(3):313-328. doi: 10.1002/hep4.1139. eCollection 2018 Mar. PMID: 29507905; PMCID: PMC5831029.
Copy
Download .nbib